Viewing nowCombinationEzerosuzon 10/2.5 mg (Ezetimibe, Rosuvastatin)
Rosuvastatin Calcium Micronized 2.6mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 202300829 · Approved 2023.03.10 · Insurance code 648508220
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps control cholesterol and related lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, it lowers total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels, while increasing HDL cholesterol, which is known as good cholesterol. This medication is used in conjunction with dietary measures and helps improve blood lipid levels to reduce the risk of cardiovascular disease. Thus, it is suitable for those needing cholesterol management and is used to maintain healthy lipid levels.
This drug is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this drug is 10/2.5mg to 10/20mg once daily. The recommended initial dose is 10/2.5mg or 10/5mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting this drug or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this drug (a combination product containing the same amount of each active ingredient) for convenience.
This medication has been reported to potentially cause a rare side effect known as rhabdomyolysis, which can lead to serious muscle damage, and thus, caution is required. Patients with severe infections, hypotension, recent major surgery, trauma, metabolic or endocrine disorders, or uncontrolled seizures should temporarily suspend or discontinue this medication. It should not be used in patients with a known allergy to this medication, active liver disease or persistent unexplained liver enzyme elevations, muscle disease, certain renal impairment, women who are pregnant or breastfeeding. Special caution is advised when administering to patients at high risk for myopathy, such as those with renal impairment, hypothyroidism, family history of muscle diseases, alcoholism, or those taking certain medications concurrently. This medication contains lactose, therefore it should not be administered to patients with lactose intolerance or related genetic disorders. During treatment, if symptoms such as muscle pain, fatigue, or fever occur, immediate consultation with a physician is necessary, and tests for potential muscle damage should be carried out. Since liver function abnormalities may occur, liver function tests should be conducted before and during administration, and if liver enzyme levels rise significantly, the medication should be discontinued. This medication can raise blood sugar levels, so patients with diabetes should periodically check their blood sugar levels. As this medication may interact with other drugs, it is especially important to consult a physician or pharmacist if taking anticoagulants, fibrates, certain antibiotics, or antifungal medications. Women who are pregnant or may become pregnant must use appropriate contraception while taking this medication and should stop immediately if pregnancy is confirmed. Breastfeeding while on this medication is not recommended. The safety and efficacy of this medication in children have not been sufficiently established, thus use in children is not recommended. Caution is needed when administering to the elderly due to the risk of myopathy, and it should be administered cautiously in patients with impaired kidney or liver function. In cases of overdose, as there is no specific antidote, treatment should be symptomatic, and monitoring should be conducted through liver function and muscle enzyme tests. This medication should be kept out of reach of children, and it is safe not to transfer it to other containers.
Headache, dizziness, dental discomfort, chest pain, joint pain, microvascular coronary artery disease, lower limb fracture, positional vertigo, diabetes, hypoglycemia, chronic cholecystitis, cholelithiasis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, myasthenia gravis, ocular myasthenia, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, weakness, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, increased serum creatinine, hypertension, increased serum urea, muscle cramps, gout, erectile dysfunction, syncope, widespread pain, fatigue, numbness, paresthesia, loss of appetite, abdominal bloating, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain storage temperatures between 1 and 30 degrees Celsius to safely preserve the medication's effectiveness.
White oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium Micronized 2.6mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationRosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.